Market Place
Sourcing Support
Terns Pharma Announces Positive Data from TERN-701 Phase 1 Trial
03 Dec 2024 //
GLOBENEWSWIRE
Terns Announces Inducement Grant Under Nasdaq Rule 5635(c)(4)
02 Dec 2024 //
GLOBENEWSWIRE
Terns Pharma Appoints Heather Turner, J.D., to Board of Directors
18 Nov 2024 //
GLOBENEWSWIRE
Terns Pharma Reports Q3 2024 Financial Results & Updates
12 Nov 2024 //
GLOBENEWSWIRE
Terns Pharmaceuticals to Attend November Investor Conferences
06 Nov 2024 //
GLOBENEWSWIRE
Terns Reports Inducement Grant to Employee Under Nasdaq LR 5635(C)(4)
07 Oct 2024 //
GLOBENEWSWIRE
Terns Closes Public Offering With Full Exercise Of Underwriters` Option
12 Sep 2024 //
GLOBENEWSWIRE
Terns Announces Pricing of Upsized $150.15 Million Public Offering
10 Sep 2024 //
GLOBENEWSWIRE
Terns` oral weight-loss drug shows promise in early study, shares jump
10 Sep 2024 //
REUTERS
Terns Announces Positive Phase 1 Results With TERN-601
09 Sep 2024 //
GLOBENEWSWIRE
Terns Announces Proposed Public Offering
09 Sep 2024 //
GLOBENEWSWIRE
5 Obesity Readouts to Watch in the Second Half of 2024
09 Aug 2024 //
BIOSPACE
Terns Pharma Reports Q2 2024 Results And Corporate Updates
05 Aug 2024 //
GLOBENEWSWIRE
Terns Pharmaceuticals Reports Inducement Grant To New Employee
01 Aug 2024 //
GLOBENEWSWIRE
Terns Pharmaceuticals Appoints New CLO And Announces CFO Transition
29 Jul 2024 //
GLOBENEWSWIRE
Terns’ ex-MASH drug cuts fat, not muscle or food intake, in GLP-1 combo in mice
25 Jun 2024 //
FIERCE BIOTECH
Terns Pharmaceuticals Preclinical Data TERN-501 GLP-1R Agonist ADA 84th Session
21 Jun 2024 //
GLOBENEWSWIRE
Terns Reports Nasdaq Employee Inducement Stock Grants
03 Jun 2024 //
GLOBENEWSWIRE
Terns Pharmaceuticals to Participate in Upcoming June Investor Conferences
30 May 2024 //
GLOBENEWSWIRE
Terns Pharmaceuticals to Participate in UBS Obesity Therapeutics Day
17 May 2024 //
GLOBENEWSWIRE
Terns Pharmaceuticals Reports Q1 2024 Results, Corporate Updates
13 May 2024 //
GLOBENEWSWIRE
Terns Pharmaceuticals Announces Leadership Changes
08 May 2024 //
GLOBENEWSWIRE
Terns Pharma at Citizens JMP Life Sciences Conference 2024
06 May 2024 //
GLOBENEWSWIRE
Terns Reports Inducement Grant Under Nasdaq Listing Rule
03 May 2024 //
GLOBENEWSWIRE
Terns Highlights TERN-701 Ph1 PK Data, Differentiation in BCR-ABL
29 Apr 2024 //
GLOBENEWSWIRE
Terns Pharmaceuticals Appoints Melita Sun Jung as Chief Business Officer
10 Apr 2024 //
GLOBENEWSWIRE
Terns Pharma Reports Fourth Quarter and Full Year 2023 Financial Results
14 Mar 2024 //
GLOBENEWSWIRE
Terns Pharmaceuticals Announces Orphan Drug Designation Granted to TERN-701
11 Mar 2024 //
GLOBENEWSWIRE
Terns Reports Inducement Grant to Employee Under Nasdaq Listing Rule 5635(C)(4)
07 Mar 2024 //
GLOBENEWSWIRE
Terns Pharmaceuticals to Participate in Upcoming March Investor Conferences
27 Feb 2024 //
GLOBENEWSWIRE
Terns Pharmaceuticals Appoints Amy Burroughs as Chief Executive Officer
07 Feb 2024 //
GLOBENEWSWIRE
Terns Pharmaceuticals Reports Inducement Grants to New Chief Executive Officer
07 Feb 2024 //
GLOBENEWSWIRE
Terns Reports Inducement Grant to Employee Under Nasdaq Listing Rule 5635(C)(4)
02 Feb 2024 //
GLOBENEWSWIRE
Terns bows out of MASH race, reverts back to phase 1
05 Jan 2024 //
FIERCE BIOTECH
Terns Pharmaceuticals to Highlight 2024 Priorities and Clinical Milestones
04 Jan 2024 //
GLOBENEWSWIRE
Terns Reports Inducement Grant to New Employee Under Nasdaq Rule 5635(C)(4)
03 Jan 2024 //
GLOBENEWSWIRE
Terns to Present at the JMP Securities Hematology and Oncology Summit
29 Nov 2023 //
GLOBENEWSWIRE
Former Terns CEO Senthil Sundaram passes away following battle with cancer
28 Nov 2023 //
ENDPTS
Terns Mourns the Loss of Senthil Sundaram, Former Chief Executive Officer
27 Nov 2023 //
GLOBENEWSWIRE
Terns Pharmaceuticals Reports Third Quarter 2023 Financial Results
14 Nov 2023 //
GLOBENEWSWIRE
Terns Pharma Presents Late-Breaking Data from Phase 2a DUET Trial of TERN-501
13 Nov 2023 //
GLOBENEWSWIRE
Terns Pharmaceuticals to Participate in Upcoming November Investor Conferences
09 Nov 2023 //
GLOBENEWSWIRE
Terns Reports Inducement Grants to Employees Under Nasdaq Rule 5635(C)(4)
03 Nov 2023 //
GLOBENEWSWIRE
Terns Announces First Participant Dosed in Phase 1 Clinical Trial of TERN-601
02 Nov 2023 //
GLOBENEWSWIRE
Terns Pharmaceuticals to Participate in Upcoming Investor Conferences
19 Oct 2023 //
GLOBENEWSWIRE
Terns Pharmaceuticals Announces Global Phase 1 Clinical Trial Design of TERN-701
16 Oct 2023 //
GLOBENEWSWIRE
Terns Reports Inducement Grants to New Employees Under Listing Rule 5635(C)(4)
03 Oct 2023 //
GLOBENEWSWIRE
Terns Reports Inducement Grants to Employees Under Nasdaq Rule 5635(C)(4)
06 Sep 2023 //
GLOBENEWSWIRE
Terns Pharmaceuticals to Participate in Upcoming September Investor Conferences
05 Sep 2023 //
GLOBENEWSWIRE
Prospective NASH market flips from failure to overcrowded
10 Aug 2023 //
FIERCE BIOTECH
Terns Pharmaceuticals touts mid-stage success for NASH drug, stock falls
09 Aug 2023 //
ENDPTS
Terns Achieves Endpoints in Phase 2a DUET Trial of THR-? Agonist TERN-501
08 Aug 2023 //
GLOBENEWSWIRE
Terns Reports Second Quarter 2023 Financial Results and Corporate Updates
08 Aug 2023 //
GLOBENEWSWIRE
Terns Pharmaceuticals` CEO Senthil Sundaram steps down for health reasons
04 Aug 2023 //
ENDPTS
Terns Pharmaceuticals Announces Leadership Transition
03 Aug 2023 //
GLOBENEWSWIRE
Terns Reports Inducement Grant to Employee Under Nasdaq Listing Rule 5635(C)(4)
03 Aug 2023 //
GLOBENEWSWIRE
Terns Pharma to Host Virtual Key Opinion Leader Event to Discuss TERN-701
18 Jul 2023 //
GLOBENEWSWIRE
Terns Reports Inducement Grants to Employees Under Nasdaq Rule 5635(C)(4)
05 Jul 2023 //
GLOBENEWSWIRE
Terns Pharmaceuticals Highlights Data for TERN-601 Program in Obesity
26 Jun 2023 //
GLOBENEWSWIRE
Terns Highlights New Preclinical Data for TERN-601 Program in Obesity
26 Jun 2023 //
PRESS RELEASE
